Finance

Lists
600332:SHA
Guangzhou Baiyunshan Pharmaceutical Holdings Ord Shs A
19,94 CNY
+0,25%
(+0,050) 1D
16 ოქტ, 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600332...
Open
19,89 CNY
High
20,19 CNY
Low
19,78 CNY
Mkt. cap
30,46 მლრდ.
Avg. vol.
5,87 მლნ.
Volume
8,94 მლნ.
Dividend
3,76%
Quarterly dividend
0,19 CNY
Ex-dividend date
10 სექ. 2026
P/E ratio
11,01
52-wk high
27,50 CNY
52-wk low
19,30 CNY
EPS
1,81 CNY
Shares outstanding
1,41 მლრდ.
No. of employees
26 ათ.
Open
19,89 CNY
High
20,19 CNY
Low
19,78 CNY
Mkt. cap
30,46 მლრდ.
Avg. vol.
5,87 მლნ.
Volume
8,94 მლნ.
Dividend
3,76%
Quarterly dividend
0,19 CNY
Ex-dividend date
10 სექ. 2026
P/E ratio
11,01
52-wk high
27,50 CNY
52-wk low
19,30 CNY
EPS
1,81 CNY
Shares outstanding
1,41 მლრდ.
No. of employees
26 ათ.
News stories
From web sources and news partners
About Guangzhou Baiyunshan Pharmaceutical Holdings Ord Shs A
CEO-
Employees26,4 ათ.
Founded1 სექ. 1997
Headquarters-
SectorHealth care provider
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
19,77 მლრდ.
16,05 მლრდ.
23,28 მლრდ.
18,81 მლრდ.
Cost of goods sold
16,58 მლრდ.
14,37 მლრდ.
18,55 მლრდ.
16,29 მლრდ.
Cost of revenue
16,58 მლრდ.
14,37 მლრდ.
18,55 მლრდ.
16,29 მლრდ.
Research and development expenses
158,44 მლნ.
217,91 მლნ.
158,68 მლნ.
184,69 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,88 მლრდ.
2,21 მლრდ.
2,22 მლრდ.
1,83 მლრდ.
Operating expense
2,05 მლრდ.
2,50 მლრდ.
2,55 მლრდ.
2,11 მლრდ.
Total operating expenses
18,63 მლრდ.
16,87 მლრდ.
21,10 მლრდ.
18,40 მლრდ.
Operating income
1,14 მლრდ.
-820,04 მლნ.
2,18 მლრდ.
409,74 მლნ.
Other non operating income
83,07 მლნ.
-100,40 მლნ.
-1,28 მლნ.
-15,15 მლნ.
EBT including unusual items
1,09 მლრდ.
-494,18 მლნ.
2,21 მლრდ.
393,99 მლნ.
EBT excluding unusual items
1,24 მლრდ.
-825,17 მლნ.
2,21 მლრდ.
377,21 მლნ.
Income tax expense
271,49 მლნ.
-156,77 მლნ.
383,93 მლნ.
59,00 მლნ.
Effective tax rate
24,82%
31,72%
17,39%
14,97%
Other operating expenses
-46,93 მლნ.
164,17 მლნ.
91,90 მლნ.
62,67 მლნ.
Net income
793,91 მლნ.
-326,94 მლნ.
1,78 მლრდ.
312,16 მლნ.
Net profit margin
4,02%
-2,04%
7,66%
1,66%
Earnings per share
-
-
-
-
Interest and investment income
117,54 მლნ.
187,01 მლნ.
140,88 მლნ.
97,52 მლნ.
Interest expense
-101,91 მლნ.
-95,60 მლნ.
-103,44 მლნ.
-110,76 მლნ.
Net interest expenses
15,64 მლნ.
91,41 მლნ.
37,44 მლნ.
-13,24 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,29 მლრდ.
-660,36 მლნ.
2,34 მლრდ.
583,55 მლნ.
Gain or loss from assets sale
3,63 მლნ.
-107,74 მლნ.
-
-938,61 ათ.
AI content may include mistakes. Learn more
Google აპები